Yifeng Pharmacy Chain Co., Ltd. (SHA:603939)

Market Cap	25.63B -24.5%
Revenue (ttm)	24.51B +1.7%
Net Income	1.73B +10.0%
EPS	1.40 +10.2%
Shares Out	1.21B
PE Ratio	15.09
Forward PE	13.32
Dividend	0.70 (3.31%)
Ex-Dividend Date	n/a

Volume	10,262,255
Open	20.98
Previous Close	21.08
Day's Range	20.74 - 21.49
52-Week Range	20.51 - 27.25
Beta	0.43
Analysts	Buy
Price Target	33.72 (+59.51%)
Earnings Date	Apr 23, 2026

About Yifeng Pharmacy Chain

Yifeng Pharmacy Chain Co., Ltd. engages in the retail business of pharmaceutical products in China. The company operates through Retail business and Wholesale business segments. The company offers Western and Chinese patent medicine, traditional Chinese medicine herbal pieces, medical devices and equipment, health supplements and products, personal care products, drugs, and convenience products related to health. It is also involved in chronic disease management, medical project investment, and medical technology development, as well as operate...

• Industry: Pharmaceutical Retailers
• Sector: Healthcare
• Founded: 2001
• Employees: 38,953
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 603939

Financial Performance

In 2025, Yifeng Pharmacy Chain's revenue was 24.43 billion, an increase of 1.54% compared to the previous year's 24.06 billion. Earnings were 1.68 billion, an increase of 9.81%.